Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 227

1.

Safety considerations when prescribing immunosuppression medication to pregnant women.

Gerosa M, Meroni PL, Cimaz R.

Expert Opin Drug Saf. 2014 Sep 5:1-9. [Epub ahead of print]

PMID:
25189270
[PubMed - as supplied by publisher]
2.

Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis.

Caso F, Costa L, Rigante D, Vitale A, Cimaz R, Lucherini OM, Sfriso P, Verrecchia E, Tognon S, Bascherini V, Galeazzi M, Punzi L, Cantarini L.

Autoimmun Rev. 2014 Aug 23. pii: S1568-9972(14)00154-2. doi: 10.1016/j.autrev.2014.08.010. [Epub ahead of print] Review.

PMID:
25182201
[PubMed - as supplied by publisher]
3.

Erratum to: Glucocorticoid-Associated Osteoporosis in Chronic Inflammatory Diseases: Epidemiology, Mechanisms, Diagnosis, and Treatment.

von Scheven E, Corbin KJ, Stagi S, Cimaz R.

Curr Osteoporos Rep. 2014 Sep;12(3):383. doi: 10.1007/s11914-014-0230-3. No abstract available.

PMID:
25103851
[PubMed - in process]
4.

Biological treatments in Behçet's disease: beyond anti-TNF therapy.

Caso F, Costa L, Rigante D, Lucherini OM, Caso P, Bascherini V, Frediani B, Cimaz R, Marrani E, Nieves-Martín L, Atteno M, Raffaele CG, Tarantino G, Galeazzi M, Punzi L, Cantarini L.

Mediators Inflamm. 2014;2014:107421. doi: 10.1155/2014/107421. Epub 2014 Jun 30.

PMID:
25061259
[PubMed - in process]
Free PMC Article
5.

Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Davì S, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, Bovis F, Cimaz R, Gamir ML, Ilowite N, Kone-Paut I, Feitosa de Oliveira SK, McCurdy D, Silva CA, Sztajnbok F, Tsitsami E, Unsal E, Weiss JE, Wulffraat N, Abinun M, Aggarwal A, Apaz MT, Astigarraga I, Corona F, Cuttica R, D'Angelo G, Eisenstein EM, Hashad S, Lepore L, Mulaosmanovic V, Nielsen S, Prahalad S, Rigante D, Stanevicha V, Sterba G, Susic G, Takei S, Trauzeddel R, Zletni M, Ruperto N, Martini A, Cron RQ, Ravelli A; on behalf of the Pediatric Rheumatology International Trials Organization; the Childhood Arthritis & Rheumatology Research Alliance; the Pediatric Rheumatology Collaborative Study Group; the Histiocyte Society.

Arthritis Rheumatol. 2014 Jul 7. doi: 10.1002/art.38769. [Epub ahead of print]

PMID:
25044674
[PubMed - as supplied by publisher]
6.

Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment.

von Scheven E, Corbin KJ, Stefano S, Cimaz R.

Curr Osteoporos Rep. 2014 Sep;12(3):289-99. doi: 10.1007/s11914-014-0228-x.

PMID:
25001898
[PubMed - in process]
7.

The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy.

Cantarini L, Vitale A, Lucherini OM, De Clemente C, Caso F, Costa L, Emmi G, Silvestri E, Magnotti F, Maggio MC, Prinzi E, Lopalco G, Frediani B, Cimaz R, Galeazzi M, Rigante D.

Clin Rheumatol. 2014 Jun 24. [Epub ahead of print]

PMID:
24953660
[PubMed - as supplied by publisher]
8.

Adalimumab in the treatment of immune-mediated diseases.

Lapadula G, Marchesoni A, Armuzzi A, Blandizzi C, Caporali R, Chimenti S, Cimaz R, Cimino L, Gionchetti P, Girolomoni G, Lionetti P, Marcellusi A, Mennini FS, Salvarani C.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):33-48. Review.

PMID:
24774505
[PubMed - indexed for MEDLINE]
9.

anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab.

Armuzzi A, Lionetti P, Blandizzi C, Caporali R, Chimenti S, Cimino L, Gionchetti P, Girolomoni G, Lapadula G, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Cimaz R.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):11-32. Review.

PMID:
24774504
[PubMed - indexed for MEDLINE]
10.

The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.

Blandizzi C, Gionchetti P, Armuzzi A, Caporali R, Chimenti S, Cimaz R, Cimino L, Lapadula G, Lionetti P, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Girolomoni G.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):1-10. Review.

PMID:
24774503
[PubMed - indexed for MEDLINE]
11.

Current evidence of anti-tumor necrosis factor α treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs.

Simonini G, Druce K, Cimaz R, Macfarlane GJ, Jones GT.

Arthritis Care Res (Hoboken). 2014 Jul;66(7):1073-84. doi: 10.1002/acr.22214. Review.

PMID:
24740981
[PubMed - indexed for MEDLINE]
12.

Does switching anti-TNFα biologic agents represent an effective option in childhood chronic uveitis: the evidence from a systematic review and meta-analysis approach.

Simonini G, Katie D, Cimaz R, Macfarlane GJ, Jones GT.

Semin Arthritis Rheum. 2014 Aug;44(1):39-46. doi: 10.1016/j.semarthrit.2014.03.001. Epub 2014 Mar 6.

PMID:
24709278
[PubMed - in process]
13.

Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling.

Rice GI, del Toro Duany Y, Jenkinson EM, Forte GM, Anderson BH, Ariaudo G, Bader-Meunier B, Baildam EM, Battini R, Beresford MW, Casarano M, Chouchane M, Cimaz R, Collins AE, Cordeiro NJ, Dale RC, Davidson JE, De Waele L, Desguerre I, Faivre L, Fazzi E, Isidor B, Lagae L, Latchman AR, Lebon P, Li C, Livingston JH, Lourenço CM, Mancardi MM, Masurel-Paulet A, McInnes IB, Menezes MP, Mignot C, O'Sullivan J, Orcesi S, Picco PP, Riva E, Robinson RA, Rodriguez D, Salvatici E, Scott C, Szybowska M, Tolmie JL, Vanderver A, Vanhulle C, Vieira JP, Webb K, Whitney RN, Williams SG, Wolfe LA, Zuberi SM, Hur S, Crow YJ.

Nat Genet. 2014 May;46(5):503-9. doi: 10.1038/ng.2933. Epub 2014 Mar 30.

PMID:
24686847
[PubMed - indexed for MEDLINE]
14.

Serum amyloid-A in Behçet's disease.

Vitale A, Rigante D, Lopalco G, Brizi MG, Caso F, Franceschini R, Denaro R, Galeazzi M, Punzi L, Iannone F, Lapadula G, Simpatico A, Marrani E, Costa L, Cimaz R, Cantarini L.

Clin Rheumatol. 2014 Aug;33(8):1165-7.

PMID:
24659331
[PubMed - in process]
15.

Etanercept - TNF receptor and IgG1 Fc fusion protein: is it different from other TNF blockers?

Marotte H, Cimaz R.

Expert Opin Biol Ther. 2014 May;14(5):569-72. doi: 10.1517/14712598.2014.896334. Epub 2014 Mar 10.

PMID:
24611432
[PubMed - in process]
16.

Brief report: etanercept inhibits the tumor necrosis factor α-driven shift of Th17 lymphocytes toward a nonclassic Th1 phenotype in juvenile idiopathic arthritis.

Maggi L, Cimaz R, Capone M, Santarlasci V, Querci V, Simonini G, Nencini F, Liotta F, Romagnani S, Maggi E, Annunziato F, Cosmi L.

Arthritis Rheumatol. 2014 May;66(5):1372-7. doi: 10.1002/art.38355.

PMID:
24470328
[PubMed - indexed for MEDLINE]
17.

The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up.

Cantarini L, Rigante D, Merlini G, Vitale A, Caso F, Lucherini OM, Sfriso P, Frediani B, Punzi L, Galeazzi M, Cimaz R, Obici L.

Semin Arthritis Rheum. 2014 Jun;43(6):818-23. doi: 10.1016/j.semarthrit.2013.12.002. Epub 2013 Dec 12.

PMID:
24393624
[PubMed - in process]
18.

Anakinra treatment in drug-resistant Behcet's disease: a case series.

Cantarini L, Vitale A, Scalini P, Dinarello CA, Rigante D, Franceschini R, Simonini G, Borsari G, Caso F, Lucherini OM, Frediani B, Bertoldi I, Punzi L, Galeazzi M, Cimaz R.

Clin Rheumatol. 2013 Dec 5. [Epub ahead of print]

PMID:
24305945
[PubMed - as supplied by publisher]
19.

Mucopolysaccharidoses.

Cimaz R, La Torre F.

Curr Rheumatol Rep. 2014 Jan;16(1):389. doi: 10.1007/s11926-013-0389-0. Review.

PMID:
24264718
[PubMed - indexed for MEDLINE]
20.

Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis.

Pagnini L, Simonini G, Giani T, Marrani E, Moretti D, Vannucci G, Cantarini L, Cimaz R.

Clin Exp Rheumatol. 2014 May-Jun;32(3):408-9. Epub 2013 Nov 14.

PMID:
24238152
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk